Effect of long-term administration of cross-sex hormone therapy on serum and urinary uric acid in transsexual persons

Journal of Clinical Endocrinology and Metabolism

Volumn 93, Issue 6, 2008, Pages 2230-2233

  Yahyaoui, Raquel ^a,b   Esteva, I ^a   Haro Mora, J J ^a   Almaraz, M C ^a   Morcillo, S ^a   Rojo Martinez G ^a   Martinez J ^a   Gomez Zumaquero J M ^a   Gonzalez I ^a   Hernando, V ^a   Soriguer, F ^a  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^b NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYPROTERONE ACETATE; ESTRADIOL; ESTRADIOL VALERATE; ESTROGEN; URIC ACID;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; ESTROGEN ACTIVITY; FEMALE; FEMALE TO MALE TRANSSEXUAL; GENDER DYSPHORIA; HOMEOSTASIS; HORMONAL THERAPY; HORMONE ACTION; HUMAN; HUMAN EXPERIMENT; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; MALE TO FEMALE TRANSSEXUAL; NORMAL HUMAN; PRIORITY JOURNAL; TRANSSEXUALISM; URIC ACID BLOOD LEVEL; URIC ACID URINE LEVEL;

EID: 45149102650     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2007-2467     Document Type: Article

References (24)

1. Mikkelsen WM, Dodge HJ, Valkenburg H 1965 The distribution of serum uric acid values in a population unselected as to gout or hyperuricemia. Am J Med 39:242-251
2. Wolfson WQ, Hunt HD, Levine R, et al 1949 The transport and excretion of uric acid in man. Sex difference in the urate metabolism. J Clin Endocrinol Metab 9:749-767
3. Scott JT, Pollard AD 1970 Uric acid excretion in the relatives of patients with gout. Ann Rheum Dis 29:327-340
4. Nicholls A, Snaith ML, Scott JT 1973 Effect of oestrogen therapy on plasma and urinary levels of uric acid. BMJ 1:449-451
5. Sumino H, Ichikawa S, Kanda T, Nakamura T, Sakamaki T 1999 Reduction of serum uric acid by hormone replacement therapy in postmenopausalwomen with hyperuricaemia. Lancet 354:650
6. Mateos Antón F, Garcia Puig J, Ramos T, González P, Ordás J 1986 Sex differences in uric acid metabolism in adults: evidence for a lack of influence of estradiol-17β (E2) on the renal handling of urate. Metabolism 35:343-348
7. Facchini F, Chen I, Holenbeck CB, Reaven GM 1991 Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and the plasma uric acid concentration. JAMA 266:3008-3011
8. Quiñones Galvan A, Natali A, Baldi S, Frascerra S, Sanna G, Ciociaro D, Ferrannini E 1995 Effect of insulin on uric acid excretion in humans. Am J Physiol 268:1-5
9. Tinahones FJ, Cardona F, Rojo-Martinez G, Almaraz MC, Cardona I, Vazquez-Mellado J, Garrido-Sanchez L, Collantes E, Soriguer F 2007 Decreased levels of uric acid after oral glucose challenge is associated with triacylglycerol levels and degree of insulin resistance. Br J Nutr 29:1-5
10. Brussaard HE, Gevers JA, Frolich M, Kluft C, Krans HMJ 1997 Short term oestrogen replacement therapy improves insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM. Diabetologia 40:843-849
11. The Harry Benjamin International Gender Dysphoria Association (HBIGDA) 2001 The standards of care for gender identity disorders. 6th version. Int J Transgender 5(1). http://www.wpath.org/publications_standards.cfm
12. Kirk S 1997 Feminizing hormonal therapy for the transgendered, Together lifeworks. Pittsburgh
13. Israel GE, Tarver II DE 1997 Transgender Hormone administration. In: Transgender care. Philadelphia: Temple University Press
14. Fabris B, Trombetta C, Belgrano E 1999 Terapia medica. In: Belgrano E, Fabris B, Trombetta C, eds. Il transessualismo, identificazione di un percorso diagnostico e terapéutico. Milano, Italy: Kurtis Editrice
15. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment: insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
16. Christodoulakos G, Lambrinoudaki I, Panoulis C, Sioulas V, Rizos D, Caramalis G, Botsis D, Creatsas G 2005 Serum androgen levels and insulin resistance in postmenopausal women: association with hormone therapy, tibolone and raloxifene. Maturitas 50:321-330
17. Rojo-Mart?́nez G, Esteva I, Ruiz de Adana MS, Catalá M, Merelo MJ, Tinahones F, Gómez-Zumaquero JM, Cuesta AL, Cardona F, Soriguer F 2004 Patterns of insulin resistance in the general population of southeast Spain. Diabetes Res Clin Pract 65:247-256
18. Polderman KH, Gooren LJG, Asscheman H, Bakker A, Heine RJ 1993 Induction of insulin resistance by androgens and estrogens. J Clin Endocrinol Metab 79:265-271
19. Elbers JM, Giltay EJ, Teerlink T, Scheffer PG, Asscheman H, Seidell JC, Gooren LJ 2003 Effects of sex steroids on components of the insulin resistance syndrome in transsexual subjects. Clin Endocrinol (Oxf) 58:562-571
20. Rosen R, Tomer Y, Carel R, Weinberger A 1994 Serum 17β-estradiol and testosterone levels in asymptomatic hyperuricaemic men. Clin Rheumatol 13: 219-223
21. Darlington LG, Ainsworth JG, Blight A, Khong MD, Mann TA, Waldon RD, Warburton EA 1991 Changes in urate metabolism after castration of patients suffering from carcinoma of the prostate. Adv Exp Med Biol 309A: 235-238
22. Burghen GA, Givens JR, Kitabchi AE 1980 Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. J Clin Endocrinol Metab 50:113-116
23. Strasak A, Ruttmann E, Brant L, Kelleher C, Klenk J, Concin H, Diem G, Pfeiffer K, Ulmer H; VHM&PP Study Group 2008 Serum uric acid and risk of cardiovascular mortality: a prospective long-term study of 83.683 Austrian men. Clin Chem 54:273-284
24. Ruggiero C, Cherubini A, Ble A, Bos AJ, Maggio M, Dixit VD, Lauretani F, Bandinelli S, Senin U, Ferrucci L 2006 Uric acid and inflammatory markers. Eur Heart J 27:1174-1181